Leprosy, an Overview
Identifieur interne : 000F93 ( Istex/Corpus ); précédent : 000F92; suivant : 000F94Leprosy, an Overview
Auteurs : Mauricio Goihman-YahrSource :
- International Journal of Dermatology [ 0011-9059 ] ; 1982-10.
Url:
DOI: 10.1111/j.1365-4362.1982.tb03175.x
Links to Exploration step
ISTEX:C619CF79B5667B398ABDB4458AE3D09493D520CELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Leprosy, an Overview</title><author><name sortKey="Goihman Ahr, Mauricio" sort="Goihman Ahr, Mauricio" uniqKey="Goihman Ahr M" first="Mauricio" last="Goihman-Yahr">Mauricio Goihman-Yahr</name><affiliation><mods:affiliation>Department of Dermatology, Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela</mods:affiliation></affiliation><affiliation><mods:affiliation>Mauricio Coihman‐Yahr, M.D., Apartado de Correos 47032, Los Chaguaramosa, Caracas 1041 A, Venezuela.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C619CF79B5667B398ABDB4458AE3D09493D520CE</idno><date when="1982" year="1982">1982</date><idno type="doi">10.1111/j.1365-4362.1982.tb03175.x</idno><idno type="url">https://api.istex.fr/document/C619CF79B5667B398ABDB4458AE3D09493D520CE/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000F93</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F93</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Leprosy, an Overview</title><author><name sortKey="Goihman Ahr, Mauricio" sort="Goihman Ahr, Mauricio" uniqKey="Goihman Ahr M" first="Mauricio" last="Goihman-Yahr">Mauricio Goihman-Yahr</name><affiliation><mods:affiliation>Department of Dermatology, Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela</mods:affiliation></affiliation><affiliation><mods:affiliation>Mauricio Coihman‐Yahr, M.D., Apartado de Correos 47032, Los Chaguaramosa, Caracas 1041 A, Venezuela.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">International Journal of Dermatology</title><idno type="ISSN">0011-9059</idno><idno type="eISSN">1365-4632</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1982-10">1982-10</date><biblScope unit="volume">21</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="423">423</biblScope><biblScope unit="page" to="431">431</biblScope></imprint><idno type="ISSN">0011-9059</idno></series><idno type="istex">C619CF79B5667B398ABDB4458AE3D09493D520CE</idno><idno type="DOI">10.1111/j.1365-4362.1982.tb03175.x</idno><idno type="ArticleID">IJD423</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0011-9059</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Mauricio Goihman‐Yahr M.D.</name><affiliations><json:string>Department of Dermatology, Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela</json:string><json:string>Mauricio Coihman‐Yahr, M.D., Apartado de Correos 47032, Los Chaguaramosa, Caracas 1041 A, Venezuela.</json:string></affiliations></json:item></author><articleId><json:string>IJD423</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>reviewArticle</json:string></originalGenre><qualityIndicators><score>6.512</score><pdfVersion>1.6</pdfVersion><pdfPageSize>552 x 779 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>0</abstractCharCount><pdfWordCount>7085</pdfWordCount><pdfCharCount>44893</pdfCharCount><pdfPageCount>10</pdfPageCount><abstractWordCount>1</abstractWordCount></qualityIndicators><title>Leprosy, an Overview</title><refBibs><json:item><author><json:item><name>DES Steward Tull</name></json:item><json:item><name>M Davies</name></json:item></author><host><volume>6</volume><pages><first>909</first></pages><author></author><title>Infect immun</title></host><title>Adjuvant activity of Mycobacterium leprae</title></json:item><json:item><author><json:item><name>W Kirchheimer</name></json:item></author><host><volume>49</volume><pages><first>209</first></pages><author></author><title>Jpn J Leprosy</title></host><title>Advances in Biomedial Leprosy Research</title></json:item><json:item><author><json:item><name>J Convit</name></json:item></author><host><volume>24</volume><pages><first>605</first></pages><author></author><title>J Reticuloendothel Soc</title></host><title>Indigenous leprosy in the armadillo (Editorial)</title></json:item><json:item><author><json:item><name>J Convit</name></json:item><json:item><name>ME Pinardi</name></json:item></author><host><volume>184</volume><pages><first>1191</first></pages><author></author><title>Science</title></host><title>Leprosy: Confirmation in the armadillo</title></json:item><json:item><author><json:item><name>WF Kirchheimer</name></json:item><json:item><name>EE Storrs</name></json:item></author><host><volume>39</volume><pages><first>693</first></pages><author></author><title>Int J Leprosy</title></host><title>Attempts to establish the armadillo (Dasypus novemcinctus Lim.). As a model for the study of leprosy. I. Report of lepromatoid leprosy in an infected armadillo</title></json:item><json:item><author><json:item><name>GP Walsh</name></json:item><json:item><name>EE Storrs</name></json:item><json:item><name>WM Meyers</name></json:item></author><host><volume>22</volume><pages><first>363</first></pages><author></author><title>J Reticuloendothel Soc</title></host><title>Naturally acquired leprosy‐like disease in the nine banded armadillo (Dasypus novemcinctus) recent epizootiologic findings</title></json:item><json:item><author><json:item><name>JH Smith</name></json:item><json:item><name>SK File</name></json:item><json:item><name>BA Nagy</name></json:item></author><host><volume>24</volume><pages><first>705</first></pages><author></author><title>J Reticuloendothel Soc</title></host><title>Leprosy‐like disease of wild armadillos in French Acadiana, Louisiana</title></json:item><json:item><host><volume>6</volume><pages><first>504</first></pages><author></author><title>Int J Leprosy</title></host></json:item><json:item><host><volume>6</volume><pages><first>205</first></pages><author></author><title>Binford CH, Meyers WM: Leprosy in pathology of tropical and extraordinary diseases, vol 1. Edited byBinford CH, Connor DH. Washington , DC , Armed Forces Institute of Pathology. 1976, pp205ff</title></host></json:item><json:item><author><json:item><name>DS Ridley</name></json:item></author><host><volume>51</volume><pages><first>451</first></pages><author></author><title>Bull WHO</title></host><title>Histological classification and the Immunological spectrum of leprosy</title></json:item><json:item><author><json:item><name>J Boddingius</name></json:item></author><host><pages><first>271</first></pages><author></author><title>Leprosy</title></host><title>Ultrastructure of beginning and progressive nerve involvement in leprosy patients</title></json:item><json:item><author><json:item><name>CK Job</name></json:item></author><host><pages><first>277</first></pages><author></author><title>Leprosy</title></host><title>Pathological and immunological basis for medical intervention in leprous neuritis</title></json:item><json:item><author><json:item><name>SM Chandi</name></json:item><json:item><name>CJG Chacko</name></json:item><json:item><name>EP Fritschi</name></json:item><json:item><name>CK Job</name></json:item></author><host><volume>48</volume><pages><first>41</first></pages><author></author><title>Int J Leprosy</title></host><title>Segmental necrotizing granulomatous neuritis of leprosy</title></json:item><json:item><author><json:item><name>V Möller‐Christensen</name></json:item></author><host><volume>33</volume><pages><first>603</first></pages><author></author><title>Int J Leprosy</title></host><title>New knowledge of leprosy through paleopathology</title></json:item><json:item><author><json:item><name>V Möller‐Christensen</name></json:item><json:item><name>DL Weiss</name></json:item></author><host><volume>39</volume><pages><first>172</first></pages><author></author><title>Int J Leprosy</title></host><title>One of the oldest datable skeletons with leprous bone changes from the Naestved Leprosy Hospital Churchyard in Denmark</title></json:item><json:item><author><json:item><name>AS Cöloglu</name></json:item></author><host><volume>50</volume><pages><first>213</first></pages><author></author><title>Lepr Rev</title></host><title>Immune complex glomerulo‐nephritis in leprosy</title></json:item><json:item><author><json:item><name>JC Gupta</name></json:item><json:item><name>UN Gandagule</name></json:item><json:item><name>JP Nigam</name></json:item></author><host><volume>52</volume><pages><first>557</first></pages><author></author><title>Leprosy in India</title></host><title>A clinicopathological study of laryngeal lesions in 30 cases of leprosy</title></json:item><json:item><author><json:item><name>CK Job</name></json:item></author><host><pages><first>175</first></pages><author></author><title>A window on Leprosy</title></host><title>Pathology of leprosy</title></json:item><json:item><author><json:item><name>R Singh</name></json:item><json:item><name>RV Koranne</name></json:item></author><host><volume>51</volume><pages><first>451</first></pages><author></author><title>Leprosy in India</title></host><title>Systemic involvement in tuberculoid leprosy. Pathogenesis of leprosy</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item></author><host><volume>48</volume><pages><first>435</first></pages><author></author><title>Int J Lepr</title></host><title>Thoughts on the immunology of leprosy (Editorial)</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>RW Ferraresi</name></json:item><json:item><name>S Raffel</name></json:item></author><host><volume>130</volume><pages><first>390</first></pages><author></author><title>Proc Soc Exp Biol Med</title></host><title>Passive transfer of hypersensitivity to lepromin</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>S Raffel</name></json:item><json:item><name>RW Ferraresi</name></json:item></author><host><volume>53</volume><pages><first>217</first></pages><author></author><title>J Invest Dermatol</title></host><title>Effects of methotrexate upon the experimental Mitsuda reaction</title></json:item><json:item><author><json:item><name>J Convit</name></json:item><json:item><name>JL Avila</name></json:item><json:item><name>M Goihman</name></json:item></author><host><volume>46</volume><pages><first>821</first></pages><author></author><title>Bull WHO</title></host><title>A test for the determination of competency in clearing bacilli in leprosy patients</title></json:item><json:item><author><json:item><name>E Rodríguez‐Paradisi</name></json:item><json:item><name>Y Bonaparte</name></json:item><json:item><name>MD Morgenfeld</name></json:item></author><host><volume>ii</volume><pages><first>308</first></pages><author></author><title>Lancet</title></host><title>Blasts in lepromatous leprosy</title></json:item><json:item><author><json:item><name>DS Waldorf</name></json:item><json:item><name>JN Sheagren</name></json:item><json:item><name>JR Trautman</name></json:item></author><host><volume>ii</volume><pages><first>773</first></pages><author></author><title>Lancet</title></host><title>Impaired delayed hypersensitivity in patients with lepromatous leprosy</title></json:item><json:item><author><json:item><name>S Sivamani</name></json:item><json:item><name>BR Garg</name></json:item><json:item><name>S Lai</name></json:item></author><host><volume>53</volume><pages><first>45</first></pages><author></author><title>Leprosy in India</title></host><title>Quantitative DNCB epicutaneous sensitization in leprosy patients and controls</title></json:item><json:item><author><json:item><name>TH Rea</name></json:item><json:item><name>NE Levan</name></json:item></author><host><volume>48</volume><pages><first>120</first></pages><author></author><title>Int J Lepr</title></host><title>Variations in dinitrochlorobenzene responsitivity in untreated leprosy: Evidence for a beneficial role for anergy</title></json:item><json:item><author><json:item><name>WR Faber</name></json:item><json:item><name>DL Leiker</name></json:item><json:item><name>IM Nangerman</name></json:item></author><host><volume>22</volume><pages><first>647</first></pages><author></author><title>Infect Immun</title></host><title>Lymphocyte transformation test in leprosy. Decreased lymphocyte reactivity to Mycobacterium leprae in lepromatous leprosy, with no evidence for a generalized impairment</title></json:item><json:item><author><json:item><name>WE Bullock</name></json:item><json:item><name> Leprosy</name></json:item></author><host><volume>137</volume><pages><first>341</first></pages><author></author><title>J Infect Dis</title></host><title>A model of immunological perturbation in chronic infection</title></json:item><json:item><author><json:item><name>M Ulrich</name></json:item><json:item><name>B Salas</name></json:item><json:item><name>J Convit</name></json:item></author><host><volume>40</volume><pages><first>4</first></pages><author></author><title>Int J Lepro</title></host><title>Lymphocyte transformation with phytomitogens in leprosy</title></json:item><json:item><author><json:item><name>TH Rea</name></json:item><json:item><name>F Quismorio</name></json:item><json:item><name>B Harding</name></json:item></author><host><volume>44</volume><pages><first>250</first></pages><author></author><title>Int J Leprosy</title></host><title>Quantitative dinitrochlorobenzene (DNCB) responsitivity and phytohemag‐glutinin (PHA) induced lymphocyte transformation in patients with lepromatous leprosy</title></json:item><json:item><author><json:item><name>R Edelman</name></json:item></author><host><volume>51</volume><pages><first>376</first></pages><author></author><title>Leprosy in India</title></host><title>Malnutrition and leprosy. An analytical review</title></json:item><json:item><author><json:item><name>B Kumar</name></json:item><json:item><name>S Kaur</name></json:item><json:item><name>NK Ganguly</name></json:item></author><host><volume>52</volume><pages><first>405</first></pages><author></author><title>Leprosy in India</title></host><title>Cutaneous response to antigens and irritants in patients of leprosy</title></json:item><json:item><author><json:item><name>MJ Ridley</name></json:item><json:item><name>DS Ridley</name></json:item><json:item><name>JL Turk</name></json:item></author><host><volume>125</volume><pages><first>91</first></pages><author></author><title>J Pathol</title></host><title>Surface markers on lymphocytes and cells of the mononuclear phagocytes series in skin sections in leprosy</title></json:item><json:item><author><json:item><name>RFM Lai‐A‐Fat</name></json:item><json:item><name>J Chan Pin Jin</name></json:item><json:item><name>M Diesselhof Den‐Dulk</name></json:item></author><host><volume>25</volume><pages><first>891</first></pages><author></author><title>Infect Immun</title></host><title>In vitro synthesis of humoral factors (immunoglobulins and complement) in lesional skin of leprosy patients</title></json:item><json:item><author><json:item><name>RFM Lai‐A‐Fat</name></json:item><json:item><name>J Chan Pin Jin</name></json:item><json:item><name>R Van Furth</name></json:item></author><host><volume>27</volume><pages><first>197</first></pages><author></author><title>Infect Immun</title></host><title>In vitro synthesis of antimycobacterial antibodies in biopsies from skin lesions of leprosy patients</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>S Raffel</name></json:item><json:item><name>RW Ferraresi</name></json:item></author><host><volume>100</volume><pages><first>635</first></pages><author></author><title>J Bacteriol</title></host><title>Delayed hypersensitivity in relation to suppression of growth of Listeria monocytogenes by guinea pig macrophages</title></json:item><json:item><author><json:item><name>LW Poulter</name></json:item></author><host><volume>40</volume><pages><first>117</first></pages><author></author><title>Cell Immunol</title></host><title>Systemic immunological reactivity in the absence of d delayed‐type hypersensitivity during murine leprosy</title></json:item><json:item><author><json:item><name>E Skamene</name></json:item><json:item><name>PAL Kongshavn</name></json:item><json:item><name>DH Sachs</name></json:item></author><host><volume>139</volume><pages><first>228</first></pages><author></author><title>J Infect Dis</title></host><title>Resistance to Listeria monocytogenes in mice. Genetic control by genes that are not linked to the H‐2 complex</title></json:item><json:item><author><json:item><name>O Closs</name></json:item><json:item><name>M Lovik</name></json:item></author><host><volume>29</volume><pages><first>17</first></pages><author></author><title>Infect Immun</title></host><title>Protective immunity and delayed‐type hyper‐sensitivity in C57BL mice after immunization with live Mycobacterium lepraemurium and sonicated bacilli</title></json:item><json:item><author><json:item><name>C Fava‐Netto</name></json:item></author><host><volume>26</volume><pages><first>349</first></pages><author></author><title>Mycopathol Mycol Appl</title></host><title>The immunology of South American Blastomycosls</title></json:item><json:item><host><author></author><title>The serology of Paracoccidioidomycosis. Present and future trends. ParacoccidioidomycosisProceeding of The First Pan‐American Symposium (PHO/WHO) Medellin‐Colombia</title></host></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>J Convit</name></json:item><json:item><name>ME Pinardi</name></json:item></author><host><volume>52</volume><pages><first>325</first></pages><author></author><title>An Bras Derm</title></host><title>Aspectos immunológicos en la Leishmaniasis</title></json:item><json:item><author><json:item><name>FE Swatek</name></json:item></author><host><pages><first>74</first></pages><author></author><title>The Epidemiology of Human Mycotic Diseases</title></host><title>The epidemiology of Coccidioidomycosis</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>E Essenfeld‐Yahr</name></json:item><json:item><name>MC Albornoz</name></json:item></author><host><volume>28</volume><pages><first>557</first></pages><author></author><title>Infect Immun</title></host><title>Defect of in‐vitro digestive ability of polymorphonuclear leukocytes in Paracoccidiodomycosis</title></json:item><json:item><author><json:item><name>R Turcotte</name></json:item></author><host><volume>46</volume><pages><first>358</first></pages><author></author><title>Int J Lepr</title></host><title>Suppressor cells in experimental murine leprosy</title></json:item><json:item><author><json:item><name>I Nath</name></json:item><json:item><name>RB Naramayan</name></json:item><json:item><name>NK Mehra</name></json:item></author><host><volume>2</volume><pages><first>319</first></pages><author></author><title>J Clin Lab Immunol</title></host><title>Concanavalin A induced suppressor activity in human leprosy</title></json:item><json:item><author><json:item><name>I Nath</name></json:item><json:item><name>JJ Van Rood</name></json:item><json:item><name>NK Mehra</name></json:item></author><host><volume>42</volume><pages><first>203</first></pages><author></author><title>Clin Exp Immunol</title></host><title>Natural suppressor cells in human leprosy: The role of HLA‐D identical peripheral lymphocytes and macrophages in the in‐vitro modulation of lymphoproliferative responses</title></json:item><json:item><author><json:item><name>RP Artz</name></json:item><json:item><name>RR Jacobson</name></json:item><json:item><name>WE Bullock</name></json:item></author><host><volume>41</volume><pages><first>343</first></pages><author></author><title>Clin Exp Immunol</title></host><title>Decreased suppressor cell activity in disseminated granulomatous infections</title></json:item><json:item><author><json:item><name>V Mehra</name></json:item><json:item><name>LH Mason</name></json:item><json:item><name>W Rothman</name></json:item></author><host><volume>125</volume><pages><first>1183</first></pages><author></author><title>J Immunol</title></host><title>Delineation of a human T. cell subset responsible for lepromin‐induced suppression in leprosy patients</title></json:item><json:item><author><json:item><name>J Convit</name></json:item><json:item><name>ME Pinardi</name></json:item><json:item><name>G Rodriguez‐Ochoa</name></json:item></author><host><volume>17</volume><pages><first>261</first></pages><author></author><title>Clin Exp Immunol</title></host><title>Elimination of Mycobacterium leprae subsequent to local in‐vivo activation of macrophages in lepromatous leprosy by other mycobacteria</title></json:item><json:item><author><json:item><name>AC Allison</name></json:item></author><host><volume>40</volume><pages><first>3</first></pages><author></author><title>Immunol Rev</title></host><title>Mechanisms by which activated macrophages inhibit lymphocyte responses</title></json:item><json:item><author><json:item><name>ER Unanue</name></json:item></author><host><volume>40</volume><pages><first>227</first></pages><author></author><title>Immunol Rev</title></host><title>The regulation of lymphocyte functions by the macrophage</title></json:item><json:item><author><json:item><name>KC Lee</name></json:item></author><host><volume>30</volume><pages><first>39</first></pages><author></author><title>Mol Cell Biochem</title></host><title>On the origin and mode of action of functionally distinct macrophage subpopulations</title></json:item><json:item><author><json:item><name>CA Brown</name></json:item><json:item><name>IN Brown</name></json:item><json:item><name>VS Sljivic</name></json:item></author><host><volume>1</volume><pages><first>309</first></pages><author></author><title>Parasite Immunology</title></host><title>Phagosome‐lysosome fusion. A possible prerequisite for enhancement of antibody responses in vitro by BCG, Mycobacterium leprae and Corynebacterium parvum</title></json:item><json:item><author><json:item><name>HK Prasad</name></json:item><json:item><name>AK Singh</name></json:item><json:item><name>GP Talwar</name></json:item></author><host><volume>50</volume><pages><first>539</first></pages><author></author><title>Leprosy in India</title></host><title>Ability of M. leprae, Mycobacterium W, and ICRC bacillus to produce macrophage activating factors from lymphocytes of leprosy patients</title></json:item><json:item><author><json:item><name>H Hirschberg</name></json:item></author><host><volume>34</volume><pages><first>46</first></pages><author></author><title>Clin Exp Immunol</title></host><title>The role of macrophages in the lymphoproliferative response to Mycobacterium leprae in vitro</title></json:item><json:item><author><json:item><name>I Nath</name></json:item><json:item><name>R Singh</name></json:item></author><host><volume>41</volume><pages><first>406</first></pages><author></author><title>Clin Exp Immunol</title></host><title>The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy</title></json:item><json:item><author><json:item><name>PR Madahevan</name></json:item><json:item><name>NH Antia</name></json:item></author><host><volume>48</volume><pages><first>167</first></pages><author></author><title>Int J Lepr</title></host><title>Biochemical alterations in cells following phagocytosis of M. leprae. The consequence a basic concept</title></json:item><json:item><author><json:item><name>PR Salgame</name></json:item><json:item><name>TJ Birdi</name></json:item><json:item><name>PR Madahevan</name></json:item></author><host><volume>48</volume><pages><first>172</first></pages><author></author><title>Int J Lepr</title></host><title>Role of macrophages in defective cell‐mediated immunity in lepromatous leprosy. I. Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation</title></json:item><json:item><author><json:item><name>TJ Birdi</name></json:item><json:item><name>PR Salgame</name></json:item><json:item><name>PR Madahevan</name></json:item></author><host><volume>48</volume><pages><first>178</first></pages><author></author><title>Int J Lepr</title></host><title>Role of macrophages in defective cell‐mediated immunity in lepromatous leprosy. II. Macrophage and lymphocyte interaction</title></json:item><json:item><author><json:item><name>MS Chakrabarty</name></json:item><json:item><name>KK Mukherjee</name></json:item><json:item><name>SK Chakrabarty</name></json:item></author><host><volume>51</volume><pages><first>182</first></pages><author></author><title>Leprosy in India</title></host><title>Hepatitis B surface antigens (Hb‐Ag) in leprosy patients of Calcutta its prevalence and subtypes</title></json:item><json:item><author><json:item><name>J Greiner</name></json:item><json:item><name>E Schleiermacher</name></json:item><json:item><name>T Smith</name></json:item></author><host><volume>42</volume><pages><first>201</first></pages><author></author><title>Hum Genetics</title></host><title>The HLA system and leprosy in Thailand</title></json:item><json:item><author><json:item><name>S Najakima</name></json:item><json:item><name>S Kobayashi</name></json:item><json:item><name>M Nohara</name></json:item></author><host><volume>45</volume><pages><first>273</first></pages><author></author><title>Int J Lepr</title></host><title>HLA‐antigen and susceptibility to leprosy</title></json:item><json:item><author><json:item><name>RM Nakamura</name></json:item><json:item><name>T Tokunaga</name></json:item></author><host><volume>22</volume><pages><first>657</first></pages><author></author><title>Infect Immun</title></host><title>Strain difference of delayed‐type hypersensitivity to BCG and its genetic control in mice</title></json:item><json:item><author><json:item><name>TH Rea</name></json:item><json:item><name>NE Levan</name></json:item><json:item><name>PJ Tekasaki</name></json:item></author><host><volume>134</volume><pages><first>615</first></pages><author></author><title>J Infect Dis</title></host><title>Histocompatibility antigens in patients with leprosy</title></json:item><json:item><author><json:item><name>GL Stoner</name></json:item><json:item><name>J Touw</name></json:item><json:item><name>A Belehu</name></json:item></author><host><volume>ii</volume><pages><first>543</first></pages><author></author><title>Lancet</title></host><title>In vitro lymphoproliferative response to Mycobacterium leprae of HLA‐D indentical siblings of lepromatous leprosy patients</title></json:item><json:item><author><json:item><name>GL Stoner</name></json:item></author><host><volume>46</volume><pages><first>217</first></pages><author></author><title>Int J Lepr</title></host><title>Ir genes and leprosy</title></json:item><json:item><author><json:item><name>H Takada</name></json:item><json:item><name>M Sada</name></json:item><json:item><name>S Ozawa</name></json:item></author><host><volume>11</volume><pages><first>61</first></pages><author></author><title>Tissue Antigens</title></host><title>HLA and mycobacterial infection: Increased frequency of B‐8 in Japanese leprosy</title></json:item><json:item><author><json:item><name>DG Smith</name></json:item></author><host><volume>50</volume><pages><first>163</first></pages><author></author><title>Hum Genet</title></host><title>The genetic hypothesis for susceptibility to lepromatous leprosy</title></json:item><json:item><author><json:item><name>RP De Vries</name></json:item><json:item><name>NK Mehra</name></json:item><json:item><name>MC Vaidya</name></json:item></author><host><volume>16</volume><pages><first>294</first></pages><author></author><title>Tissue Antigens</title></host><title>HLA‐linked control of susceptibility to tuberculoid leprosy and association with HLA‐DR types</title></json:item><json:item><author><json:item><name>W Van Eden</name></json:item><json:item><name>RRP De Vries</name></json:item><json:item><name>NK Mehra</name></json:item></author><host><volume>141</volume><pages><first>693</first></pages><author></author><title>J Infect Dis</title></host><title>HLA segregation of tuberculoid leprosy. Confirmation of the DR1‐marker</title></json:item><json:item><author><json:item><name>PEM Tine</name></json:item><json:item><name>E Wolf</name></json:item><json:item><name>J Pritchard</name></json:item></author><host><volume>140</volume><pages><first>152</first></pages><author></author><title>J Infect Dis</title></host><title>HLA‐linked genes and leprosy. A family study in Karigiri, South India</title></json:item><json:item><author><json:item><name>RC Hastings</name></json:item><json:item><name>CK Job</name></json:item></author><host><volume>27</volume><pages><first>995</first></pages><author></author><title>Am J Trop Med Hyg</title></host><title>Reversal reactions in lepromaotus leprosy following transfer factor therapy</title></json:item><json:item><author><json:item><name>SNC Wemambu</name></json:item><json:item><name>JL Turk</name></json:item><json:item><name>MFR Waters</name></json:item></author><host><volume>ii</volume><pages><first>933</first></pages><author></author><title>Lancet</title></host><title>Erythema nodosum leprosum: A clinical manifestation of the Arthus phenomenon</title></json:item><json:item><author><json:item><name>O Rojas‐Espinosa</name></json:item><json:item><name>I Méndez‐Navarrete</name></json:item><json:item><name>S Estrada‐Parra</name></json:item></author><host><volume>12</volume><pages><first>215</first></pages><author></author><title>Clin Exp Immunol</title></host><title>Presence of C10 reactive immune complexes in patients with leprosy</title></json:item><json:item><host><author></author><title>World Health Organization: Report of the Fifth Meeting of the Scientific Working Group on the Immunology of Leprosy (IMMLEP). June, 1980</title></host></json:item><json:item><author><json:item><name>FP Quismorio</name></json:item><json:item><name>T Rea</name></json:item><json:item><name>S Chandor</name></json:item></author><host><volume>9</volume><pages><first>184</first></pages><author></author><title>Clin Immunol Immunopathol</title></host><title>Lucio's phenomenon: An immune complex deposition syndrome in lepromatous leprosy</title></json:item><json:item><author><json:item><name>KSK Tung</name></json:item><json:item><name>B Kimi</name></json:item><json:item><name>B Bjorvatn</name></json:item></author><host><volume>136</volume><pages><first>216</first></pages><author></author><title>J Infect Dis</title></host><title>Discrepancy between C10 deviation and RAJI cell tests in detection of immune complexes in patients with leprosy</title></json:item><json:item><author><json:item><name>J Anthony</name></json:item><json:item><name>MC Vaidya</name></json:item><json:item><name>A Dasgupta</name></json:item></author><host><volume>50</volume><pages><first>356</first></pages><author></author><title>Leprosy in India</title></host><title>Immunological methods employed in an attempt to induce erythema nodosum leprosum (ENL) in mice</title></json:item><json:item><author><json:item><name>PK Das</name></json:item><json:item><name>PR Klatser</name></json:item><json:item><name>KW Pondman</name></json:item></author><host><volume>1</volume><pages><first>1309</first></pages><author></author><title>Lancet</title></host><title>Dapsone and antidapsone antibody in circulating immuno complexes in leprosy patients</title></json:item><json:item><author><json:item><name>E Linder</name></json:item><json:item><name>VP Lehto</name></json:item><json:item><name>S Stenman</name></json:item></author><host><volume>13</volume><pages><first>1</first></pages><author></author><title>Clin Immunol Immunopathol</title></host><title>Circulating antibodies to connective tissue microfibrils and dermal immunoglobulin deposits in leprosy</title></json:item><json:item><author><json:item><name>GM Bahr</name></json:item><json:item><name>GAW Rook</name></json:item><json:item><name>E Moreno</name></json:item></author><host><volume>41</volume><pages><first>865</first></pages><author></author><title>Immunology</title></host><title>Use of ELISA to screen for antithymocyte and anti 2‐microglobulin antibodies in leprosy and SLE</title></json:item><json:item><author><json:item><name>JS Louie</name></json:item><json:item><name>M Glovsky</name></json:item></author><host><volume>43</volume><pages><first>252</first></pages><author></author><title>Int J Lepr</title></host><title>Complement determination in the synovial fluid and serum of a patient with erythema nodosum leprosum</title></json:item><json:item><author><json:item><name>VD Ramanathan</name></json:item><json:item><name>J Curtis</name></json:item><json:item><name>JL Turk</name></json:item></author><host><volume>29</volume><pages><first>30</first></pages><author></author><title>Infect Immunol</title></host><title>Activation of the alternate pathway of complement by mycobacterial and cord factor</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>C Rodríguez‐Ochoa</name></json:item><json:item><name>N Aranzazu</name></json:item></author><host><volume>47</volume><pages><first>570</first></pages><author></author><title>Int J Lepr</title></host><title>In vitro activation of neutrophils by suspensions of Mycobacterium leprae</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>MA Requena</name></json:item><json:item><name>E Vallecalle‐Suegart</name></json:item></author><host><volume>42</volume><pages><first>266</first></pages><author></author><title>Int J Lepr</title></host><title>Autoimmune diseases and Thalidomide II. Adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>J Convit</name></json:item><json:item><name>C Rodríguez‐Ochoa</name></json:item></author><host><volume>57</volume><pages><first>317</first></pages><author></author><title>Int Arch Allergy Appl Immunol</title></host><title>Significance of neutrophil activation in reactional lepromatous leprosy. Effects of Thalidomide in vivo and in vitro. Activation in adjuvant disease</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item></author><host><pages><first>146</first></pages><author></author><title>Leprosy</title></host><title>Aspects on research in the immunology of leprosy. Current thoughts on the pathogenesis or reactional lepromatous leprosy</title></json:item><json:item><author><json:item><name>JW Hollingsworth</name></json:item><json:item><name>DS Greenberg</name></json:item><json:item><name>M Dawson</name></json:item></author><host><volume>152</volume><pages><first>183</first></pages><author></author><title>Proc Soc Exp Biol Med</title></host><title>Adjuvant arthritis in T‐lymphocyte depleted rats</title></json:item><json:item><author><json:item><name>J Convit</name></json:item><json:item><name>ME Pinardi</name></json:item><json:item><name>JL Avila</name></json:item></author><host><volume>52</volume><pages><first>187</first></pages><author></author><title>Bull WHO</title></host><title>Specificity of the 46‐hour reaction to Mitsuda antigen. Use of a soluble antigen from human and armadillo lepromin</title></json:item><json:item><author><json:item><name>J Convit</name></json:item><json:item><name>ME Pinardi</name></json:item><json:item><name>F Arias‐Rojas</name></json:item></author><host><volume>52</volume><pages><first>193</first></pages><author></author><title>Bull WHO</title></host><title>Tests with three antigens in leprosy‐endemic and non‐endemic areas</title></json:item><json:item><author><json:item><name>HD Caldwell</name></json:item><json:item><name>WF Kirchheimer</name></json:item><json:item><name>TM Buchanan</name></json:item></author><host><volume>47</volume><pages><first>447</first></pages><author></author><title>Int J Lepr</title></host><title>Identification of a Mycobacterium leprae specific protein antigen(s) and its possible application for the serodiagnosis of leprosy</title></json:item><json:item><author><json:item><name>L Yoder</name></json:item><json:item><name>B Naafs</name></json:item><json:item><name>M Harboe</name></json:item></author><host><volume>50</volume><pages><first>113</first></pages><author></author><title>Lepr Rev</title></host><title>Antibody acitivity against mycobacterium antigen 7 in leprosy. Studies on variation in antibody content throughout the spectrum and the effect of DDS treatment and relapse in BT leprosy</title></json:item><json:item><author><json:item><name>MH Kaplan</name></json:item><json:item><name>MW Chase</name></json:item></author><host><volume>142</volume><pages><first>835</first></pages><author></author><title>J Infect Dis</title></host><title>Antibodies to mycobacteria in human tuberculosis. II. Response to nine defined mycobacterial antigens with evidence for an antibody common to tuberculosis and lepromatous leprosy</title></json:item><json:item><author><json:item><name>PJ Brennan</name></json:item><json:item><name>WW Barrow</name></json:item></author><host><volume>48</volume><pages><first>382</first></pages><author></author><title>Int J Lepr</title></host><title>Evidence for species specific lipid antigens in Mycobacterium leprae</title></json:item><json:item><author><json:item><name>M Harboe</name></json:item></author><host><volume>48</volume><pages><first>193</first></pages><author></author><title>Int J Lepr</title></host><title>Immunological aspects of leprosy: Ten years' activity at the Armauer Hansen Research Institute and prospects for further work</title></json:item><json:item><author><json:item><name>J Convit</name></json:item><json:item><name>ME Pinardi</name></json:item></author><host><volume>40</volume><pages><first>130</first></pages><author></author><title>Int J Lepr</title></host><title>A simple method for the differentiation of Mycobacterium leprae from other mycobacteria through routine staining technics</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>S Raffel</name></json:item><json:item><name>RW Ferraresi</name></json:item></author><host><volume>36</volume><pages><first>129</first></pages><author></author><title>Int J Lepr</title></host><title>Cross reactivity of lepromin with other mycobacterial antigens</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>S Raffel</name></json:item><json:item><name>RW Ferraresi</name></json:item></author><host><volume>36</volume><pages><first>450</first></pages><author></author><title>Int Arch Allergy Appl Immunol</title></host><title>Cross reactivities of lepromin</title></json:item><json:item><author><json:item><name>M Goihman‐Yahr</name></json:item><json:item><name>J Convit</name></json:item></author><host><volume>40</volume><pages><first>62</first></pages><author></author><title>Int J Lepr</title></host><title>Cross reactivity of Mycobacterium leprae and BCG a report on further studies</title></json:item><json:item><author><json:item><name>RG Navalkar</name></json:item><json:item><name>SD Chaparas</name></json:item><json:item><name>CK Lakshmimarayana</name></json:item></author><host><volume>48</volume><pages><first>388</first></pages><author></author><title>Int J Lepr</title></host><title>Antigenic evaluation of Mycobacterium vaccae in relation to Mycobacterium leprae</title></json:item><json:item><author><json:item><name>B Bjorvatn</name></json:item><json:item><name>G Krönvall</name></json:item></author><host><volume>48</volume><pages><first>260</first></pages><author></author><title>Int J Lepr</title></host><title>Detection of antigen in Norcardia caviaecross‐reactivity with mycobacterial antigens No 21 and M. Leprae using a lepromatous leprosy serum pool as antibody reagent</title></json:item><json:item><host><author></author><title>Comité de Expertos de la OMS en LepraQuinto Informe (Serie de Informes Técnicos 607)</title></host></json:item><json:item><author><json:item><name>SJ Yawalkar</name></json:item><json:item><name>W Vischer</name></json:item></author><host><pages><last>13</last><first>3</first></pages><author></author><title>Información Básica</title></host><title>Lamprén (Clofazimina) en la lepra</title></json:item><json:item><host><author></author><title>A guide to leprosy control</title></host></json:item><json:item><author><json:item><name>BK Girdhar</name></json:item><json:item><name> Sreevatsa</name></json:item><json:item><name>KV Desikan</name></json:item></author><host><volume>52</volume><pages><first>359</first></pages><author></author><title>Lepr India</title></host><title>Effect of single dose (1500 mg) Rifampicin on infectivity of patients with lepromatous leprosy</title></json:item><json:item><author><json:item><name>WE Bullock</name></json:item></author><host><volume>91</volume><pages><first>482</first></pages><author></author><title>Ann Intern Med</title></host><title>Immunology and the therapeutics of leprosy</title></json:item><json:item><author><json:item><name>WR Faber</name></json:item><json:item><name>DL Leiker</name></json:item><json:item><name>IM Nengerman</name></json:item></author><host><volume>35</volume><pages><first>45</first></pages><author></author><title>Clin Exp Immunol</title></host><title>A placebo controlled clinical trial of transfer factor in lepromatous leprosy</title></json:item><json:item><author><json:item><name>GP Talwar</name></json:item></author><host><volume>50</volume><pages><first>492</first></pages><author></author><title>Lepr India</title></host><title>Towards development of a vaccine against leprosy</title></json:item><json:item><author><json:item><name>U Sengupta</name></json:item></author><host><volume>53</volume><pages><first>88</first></pages><author></author><title>Lepr India</title></host><title>Towards a vaccine against leprosy</title></json:item><json:item><author><json:item><name>AHM Smelt</name></json:item><json:item><name>RJW Rees</name></json:item><json:item><name>FY Liew</name></json:item></author><host><volume>44</volume><pages><first>501</first></pages><author></author><title>Clin Exp Immunol</title></host><title>Induction of delayed‐type hypersensitivity to Mycobacterium leprae in healthy individuals</title></json:item><json:item><author><json:item><name>AJ Mocelin</name></json:item><json:item><name>H Ajzen</name></json:item><json:item><name>MS Ancao</name></json:item></author><host><volume>28</volume><pages><first>260</first></pages><author></author><title>Transplantation</title></host><title>Kidney transplantation in leprosy. A case report</title></json:item><json:item><author><json:item><name>J Alexander</name></json:item></author><host><volume>34</volume><pages><first>52</first></pages><author></author><title>Clin Exp Immunol</title></host><title>Effect of cyclophosphamide treatment of the course of Mycobacterium lepraemurium infection and development of delayed‐type hypersensitivity reactions in C57BL and BALB/C mice</title></json:item><json:item><author><json:item><name>J Convit</name></json:item><json:item><name>N Aranzazu</name></json:item><json:item><name>ME Pinardi</name></json:item></author><host><volume>36</volume><pages><first>214</first></pages><author></author><title>Clin Exp Immunol</title></host><title>Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda‐negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG</title></json:item><json:item><author><json:item><name>J Convit</name></json:item><json:item><name>M Ulrich</name></json:item><json:item><name>N Aranzazu</name></json:item></author><host><volume>48</volume><pages><first>62</first></pages><author></author><title>Int J Lepr</title></host><title>Vaccination in leprosy–observations and interpretations (Editorial)</title></json:item><json:item><author><json:item><name>S Izumi</name></json:item><json:item><name>K Sugiyama</name></json:item><json:item><name>Y Matsumoto</name></json:item></author><host><volume>24</volume><pages><first>733</first></pages><author></author><title>Microbiol Immunol</title></host><title>Numerical changes in T cells subsets (Tγ Tμ) in leprosy patients</title></json:item></refBibs><genre><json:string>review-article</json:string></genre><host><volume>21</volume><publisherId><json:string>IJD</json:string></publisherId><pages><total>9</total><last>431</last><first>423</first></pages><issn><json:string>0011-9059</json:string></issn><issue>8</issue><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1365-4632</json:string></eissn><title>International Journal of Dermatology</title><doi><json:string>10.1111/(ISSN)1365-4632</json:string></doi></host><categories><wos><json:string>science</json:string><json:string>dermatology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>dermatology & venereal diseases</json:string></scienceMetrix></categories><publicationDate>1982</publicationDate><copyrightDate>1982</copyrightDate><doi><json:string>10.1111/j.1365-4362.1982.tb03175.x</json:string></doi><id>C619CF79B5667B398ABDB4458AE3D09493D520CE</id><score>0.0997054</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/C619CF79B5667B398ABDB4458AE3D09493D520CE/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/C619CF79B5667B398ABDB4458AE3D09493D520CE/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/C619CF79B5667B398ABDB4458AE3D09493D520CE/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Leprosy, an Overview</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><p>WILEY</p></availability><date>1982</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Leprosy, an Overview</title><author xml:id="author-1"><persName><forename type="first">Mauricio</forename><surname>Goihman‐Yahr</surname></persName><roleName type="degree">M.D.</roleName><affiliation>Department of Dermatology, Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela</affiliation><affiliation>Mauricio Coihman‐Yahr, M.D., Apartado de Correos 47032, Los Chaguaramosa, Caracas 1041 A, Venezuela.</affiliation></author></analytic><monogr><title level="j">International Journal of Dermatology</title><idno type="pISSN">0011-9059</idno><idno type="eISSN">1365-4632</idno><idno type="DOI">10.1111/(ISSN)1365-4632</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1982-10"></date><biblScope unit="volume">21</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="423">423</biblScope><biblScope unit="page" to="431">431</biblScope></imprint></monogr><idno type="istex">C619CF79B5667B398ABDB4458AE3D09493D520CE</idno><idno type="DOI">10.1111/j.1365-4362.1982.tb03175.x</idno><idno type="ArticleID">IJD423</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1982</date></creation><langUsage><language ident="en">en</language></langUsage></profileDesc><revisionDesc><change when="1982-10">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/C619CF79B5667B398ABDB4458AE3D09493D520CE/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1365-4632</doi><issn type="print">0011-9059</issn><issn type="electronic">1365-4632</issn><idGroup><id type="product" value="IJD"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="INTERNATIONAL JOURNAL OF DERMATOLOGY">International Journal of Dermatology</title></titleGroup></publicationMeta><publicationMeta level="part" position="10008"><doi origin="wiley">10.1111/ijd.1982.21.issue-8</doi><numberingGroup><numbering type="journalVolume" number="21">21</numbering><numbering type="journalIssue" number="8">8</numbering></numberingGroup><coverDate startDate="1982-10">October 1982</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="0042300" status="forIssue"><doi origin="wiley">10.1111/j.1365-4362.1982.tb03175.x</doi><idGroup><id type="unit" value="IJD423"></id></idGroup><countGroup><count type="pageTotal" number="9"></count></countGroup><titleGroup><title type="tocHeading1">Review</title></titleGroup><eventGroup><event type="firstOnline" date="2008-03-05"></event><event type="publishedOnlineFinalForm" date="2008-03-05"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-04"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-13"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-23"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="423">423</numbering><numbering type="pageLast" number="431">431</numbering></numberingGroup><correspondenceTo>Mauricio Coihman‐Yahr, M.D., Apartado de Correos 47032, Los Chaguaramosa, Caracas 1041 A, Venezuela.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:IJD.IJD423.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="referenceTotal" number="117"></count><count type="linksCrossRef" number="2"></count></countGroup><titleGroup><title type="main">Leprosy, an Overview</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>Mauricio</givenNames><familyName>Goihman‐Yahr</familyName><degrees>M.D.</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="VE"><unparsedAffiliation>Department of Dermatology, Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela</unparsedAffiliation></affiliation></affiliationGroup></contentMeta><noteGroup><note xml:id="n-fnt-1" numbered="no"><p>Supported in part by grants from Consejo de Investigaciones Científicas y Tecnológicas (CONICIT, Venezuela), Consejo de Desarrollo Científico y Humanístico Universidad Central de Venezuela, and a special grant from the Ministerio de Sanidad y Asistencia Social, Venezuela.</p></note><note xml:id="n-fnt-2" numbered="no"><p>See also p 458.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Leprosy, an Overview</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Leprosy, an Overview</title></titleInfo><name type="personal"><namePart type="given">Mauricio</namePart><namePart type="family">Goihman‐Yahr</namePart><namePart type="termsOfAddress">M.D.</namePart><affiliation>Department of Dermatology, Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela</affiliation><affiliation>Mauricio Coihman‐Yahr, M.D., Apartado de Correos 47032, Los Chaguaramosa, Caracas 1041 A, Venezuela.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">1982-10</dateIssued><copyrightDate encoding="w3cdtf">1982</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">117</extent></physicalDescription><relatedItem type="host"><titleInfo><title>International Journal of Dermatology</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0011-9059</identifier><identifier type="eISSN">1365-4632</identifier><identifier type="DOI">10.1111/(ISSN)1365-4632</identifier><identifier type="PublisherID">IJD</identifier><part><date>1982</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><detail type="issue"><caption>no.</caption><number>8</number></detail><extent unit="pages"><start>423</start><end>431</end><total>9</total></extent></part></relatedItem><identifier type="istex">C619CF79B5667B398ABDB4458AE3D09493D520CE</identifier><identifier type="DOI">10.1111/j.1365-4362.1982.tb03175.x</identifier><identifier type="ArticleID">IJD423</identifier><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Archeologie/explor/PaleopathV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F93 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000F93 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Archeologie
|area= PaleopathV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:C619CF79B5667B398ABDB4458AE3D09493D520CE
|texte= Leprosy, an Overview
}}
| This area was generated with Dilib version V0.6.27. |  |